Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question

BACKGROUND: Diagnosis of pseudoprogression in patients with glioblastoma multiforme (GBM) is limited by Response Assessment in Neuro-Oncology (RANO) criteria to 3 months after chemoradiotherapy (CRT). Frequency of pseudoprogression occurring beyond this time limit was determined. Survival comparison...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nasseri, Morad, Gahramanov, Seymur, Netto, Joao Prola, Fu, Rongwei, Muldoon, Leslie L., Varallyay, Csanad, Hamilton, Bronwyn E., Neuwelt, Edward A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
Neuroimaging
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4096172/
https://ncbi.nlm.nih.gov/pubmed/24523362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not328
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky